TEV priming of CD4+ CAR or control T cells significantly impaired the killing activity of these cells, regardless of neurotrophin receptor expression in the SH-SY5Y target cells, whereas the TEV priming of CD8+ CAR or control T cells did not affect neuroblastoma cell cytotoxicity (Figure 2B). Here, CD8A is linked to neuroblastoma.